
0.1652 Delayed Data As of Feb 02 | ![]() Today’s Change | 0.10 Today|||52-Week Range 2.20 | +37.67% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $10.4M |
Vascular Biogenics Ltd. 8 HaSatat Street Modi’in Jerusalem 7178106 |
Dror Harats | Chief Executive Officer & Director |
Eyal Breitbart | Senior Vice President-Research & Operations |
Erez Feige | Senior Vice President-Business Operations |
Samuel I. Backenroth | Chief Financial Officer |
Tami Rachmilewitz | Senior Vice President-Clinical Development |